In a previous study, the authors demonstrated significantly higher levels of IL-6, IL-2, IL-4, and TNF-α and an increased CD4+/CD8+ ratio in patients with CIDP compared to controls. The gene discussed is IL4; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.